drugset / Trial / NCT02477072

Optimized Heparin Regimen in Vascular Surgery

NCT02477072

RandomizedParallel-groupDouble-blindTreatment

Summary

Hypothesis: Optimal anticoagulation defined as an Activated Clotting Time (ACT) of 300 to 350 seconds obtained by weight-adjusted doses of unfractionated heparin (UFH) will improve the hemostatic environment downstream from the vascular clamp, provide better blood flow in the distal bed following peripheral revascularization surgery. Objectives: This study is designed to assess the effects of an optimized regimen of UFH on the hemostatic environment downstream from the vascular clamp in major vascular surgery.

Timeline

Start
2015-09
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 100 iu/kg Intravenous
Subject Heparin Other / unclassified 5000 iu Intravenous